This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Yoshinobu Yamane
Introduction
Yoshinobu Yamane is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic potential. His work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Yamane holds a patent for a monocyclic pyridine derivative. This invention provides a novel compound that exhibits FGFR inhibitory activity or a pharmaceutically acceptable salt thereof. The patent details a pharmaceutical composition containing this compound, which is represented by a specific formula. The compound is designed to have various structural components that enhance its efficacy in medical applications.
Career Highlights
Yoshinobu Yamane is associated with Eisai R&D Management Co., Ltd., where he continues to contribute to innovative research and development in the pharmaceutical industry. His work is characterized by a commitment to advancing medical science and improving patient outcomes through novel therapeutic agents.
Collaborations
Yamane has collaborated with esteemed colleagues such as Setsuo Funasaka and Toshimi Okada. These partnerships highlight the collaborative nature of research and the importance of teamwork in achieving groundbreaking results in the field of pharmaceuticals.
Conclusion
Yoshinobu Yamane's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts underscore his role as a significant inventor. His work continues to impact the development of new therapeutic compounds, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
